Show
Sort by
-
Characterisation and classification of oligometastatic disease : a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
-
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials : recommendations of the SISAQOL Consortium
-
How public health services pay for radiotherapy in Europe : an ESTRO–HERO analysis of reimbursement
-
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia : a global, single-arm, phase 2 trial
-
Management of vertebral radiotherapy dose in paediatric patients with cancer : consensus recommendations from the SIOPE radiotherapy working group
-
Of microbes and women : BRCA1, vaginal microbiota, and ovarian cancer
-
Improving affordability of new Essential Cancer Medicines
-
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer : a phase 1 dose-escalation and dose-expansion study
-
Moonshot or groundshot : addressing Europe's cancer challenge through a patient-focused, data-enabled lens
-
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc) : a multicentre, phase 2-3, randomised, controlled trial